INDIANAPOLIS, Oct. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will present new data for Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab at the 28th annual European Academy of Dermatology and Venereology (EADV) Congress taking place Oct. 9-13 in

DENVER, Oct. 8, 2019 /PRNewswire/ -- The SAFE (Stem cell experts Advocating For Ethical treatment) study group, a panel that consisted of 27 academics and Regenerative Medicine physician experts from a dozen universities and from many different specialties, have just produced the world's first consensus re

MODESTO, Calif., Oct. 8, 2019 /PRNewswire/ -- Anti-aging regimens abound but emerging research suggests that one delicious addition to your skincare routine may be in your pantry instead of your makeup kit: almonds.

CHICAGO, Oct. 8, 2019 /PRNewswire/ -- Commercially insured Americans with Multiple Sclerosis (MS) are three times more likely to have behavioral health conditions, including major depression and substance use disorder, than the overall population, according to a new Blue Cross Blue Shield Association (BCBSA) report.

MADISON, Wis., Oct. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its third-quarter 2019 financial results after the close of the U.S. financial markets on Oct. 29, 2019. Following the release, company management will host a webcast and conference call at

MINNEAPOLIS, Oct. 8, 2019 /PRNewswire/ -- The Excelera Network was selected by

SOUTH SAN FRANCISCO, Oct. 8, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announces it has dosed its first patient with cutaneous melanoma harboring a GNAQ or GNA11 (GNAQ/11) mutation, a key milestone for evaluating Pr

CAMBRIDGE, Mass., Oct. 8, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics. Founded in 2017 in Flagship Labs, Flagship

LELYSTAD, The Netherlands, Oct. 8, 2019 /PRNewswire/ -- Today, Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides. The doubled GMP production capacity

SAN RAMON, Calif., Oct. 8, 2019 /PRNewswire/ -- BioVentrix, Inc. announced the first patient was enrolled and treated  in the REVIVE-HF European  study, a prospective multi-cen